Successfully merged with Biote (BioTE Holdings, LLC) • Now trading as BTMD
SPAC Overview
$300M
IPO Size
$318M
Trust (as of 2022-03-31)
Completed
Current Status
2021
IPO Year
Timeline Progress
About
Haymaker Acquisition Corp. III is a blank-check company seeking a business combination, with an intended focus on consumer and consumer-related products and services, while retaining the ability to pursue opportunities in any industry.
Investment Focus
Consumer
The terms and the filing trail behind Haymaker Acquisition Corp. III
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Marc D. Beer
Director, Executive Chairman
Steven J. Heyer
Chief Executive Officer, Director, Executive Chairman
Teresa Sue Weber
Chief Executive Officer, Director
Andrew R. Heyer
Director, President
Cary M. Paulette
Chief Revenue Officer, Vice President of Sales
Joseph M. Tonnos
Senior Vice President
Mary Elizabeth Conlon
Business Development, General Counsel, Vice President, Vice President, Business Development & General Counsel
Christopher Bradley
Chief Financial Officer, Secretary
Robbin Charles Gibbins
Chief Financial Officer
Samar Jagat Kamdar
Chief Financial Officer
Jade Beutler
Head of Nutraceuticals
Joseph Butler
Chief Information Officer
Richard K. Key
Chief Digital Officer
Ross Mcquivey M.D.
Chief Medical Officer
Dana Lynn Jacoby
Director
Debra L. Morris
Director
Ed Orlandi
Senior Director, Supply Chain & Facility
Jennifer Schimmel
Director, Human Resources & Talent
Mark Cone
Director
Frederic H. Mayerson
Director, Director Nominee
Roger Meltzer Esq.
Director, Director Nominee
Stephen W. Powell
Director, Director Nominee
James Mark Hincher
Beneficial owner
Mark Orr
Beneficial owner
Terry Weber
Beneficial owner
Gary Steven Donovitz
Lani Hammonds-Donovitz
Mandy Cotten
Walter Field Mclallen
Underwriters
Extended Team Information
Led by Steven J. Heyer and Andrew R. Heyer, with Christopher Bradley and Joseph M. Tonnos, the team brings consumer operating and investing experience as well as M&A, financial, and transaction experience. Several members previously led Haymaker I and Haymaker II through business combinations.
Stock Performance
BTMD
Trading Symbol
First Trade
April 28, 2021
$10.05
At Merger
June 1, 2022
$5.49
-45%
6 Months Post-Merger
November 30, 2022
$3.99
-27%
1 Year Post-Merger
May 30, 2023
$5.56
+1%
2 Years Post-Merger
May 28, 2024
$6.59
+20%
Current Price
October 1, 2026
$1.16
-88%
Key Information
IPO Date
March 3, 2021
Total Redemptions
$306M
SIC
6770
Completion Date
May 26, 2022
Merger Target
Biote (BioTE Holdings, LLC)
SPAC Ticker
HYAC
Merged Ticker
BTMD